A Randomized, Double-Blind Study of the Efficacy of Intravenous Bonviva in the Relief of Pain After Recent Vertebral Osteoporotic Fracture in Osteoporotic Patients.

Trial Profile

A Randomized, Double-Blind Study of the Efficacy of Intravenous Bonviva in the Relief of Pain After Recent Vertebral Osteoporotic Fracture in Osteoporotic Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jan 2014

At a glance

  • Drugs Ibandronic acid (Primary)
  • Indications Back pain; Male osteoporosis; Osteoporotic pain; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms BONDIR
  • Sponsors Roche
  • Most Recent Events

    • 28 Jun 2012 Planned number of patients changed from 68 to 130 as reported by European Clinical Trials Database.
    • 26 Jan 2010 Patient numbers amended from 69 to 68 as reported by ClinicalTrials.gov.
    • 18 Nov 2009 Status changed from active, no longer recruiting to completed as reported by Roche record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top